Crescent Biopharma (CBIO) announced the appointment of Jan Pinkas, Ph.D., as chief scientific officer. Prior to joining Crescent, Dr. Pinkas was CSO at Pyxis Oncology (PYXS), where he established the preclinical research and development function to support ADC and antibody programs through Investigational New Drug-enabling studies and led the translational medicine group.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBIO: